Nuveen S&P 500 Buy-Write Income Fund
BXMX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.46 | -0.02 | 0.04 | 0.04 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 0.00 | 5.65 | -6.83 | 6.24 |
| Quality | ||||
| ROIC | 0.55% | 72.84% | -13.98% | 15.65% |
| Gross Margin | 100.00% | 982.51% | 92.14% | 94.81% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -47.12% | -53.81% | 43.67% | 6.25% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.11 | -0.03 | 0.01 |
| Interest Coverage | 125.45 | 2,652.52 | -169,356.11 | 97,650.83 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 12.30 | 0.28 |
| Cash Conversion Cycle | 87.16 | 20.34 | 2.71 | 1,292.80 |